Charles Park - BlackRock Science Executive
| BST Etf | USD 37.80 0.06 0.16% |
Ms. Charles C.S. Park is Chief Compliance Officer, AntiMoney Laundering Officer of Blackrock Science And Technology Trust . She is CCO of BlackRock Advisors, LLC and the BlackRockadvised funds in the EquityBond Complex, the EquityLiquidity Complex and the ClosedEnd Complex since 2014 Principal of and CCO for iShares Delaware Trust Sponsor LLC since 2012 and BlackRock Fund Advisors since 2006 CCO for the BFAadvised iShares exchange traded funds since 2006 CCO for BlackRock Asset Management International Inc. since 2012.
| Age | 54 |
| Tenure | 10 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Charles Park Latest Insider Activity
Tracking and analyzing the buying and selling activities of Charles Park against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Charles Park insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Charles Park over a month ago Insider Trading |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
| Lindsay Sinclair | BlackRock Utility Infrastructur | N/A | |
| Thomas Faust | Eaton Vance Enhanced | 63 | |
| Albert Laskaj | Cohen And Steers | 43 | |
| William Reardon | Tekla Healthcare Investors | 74 | |
| Thomas CFA | BlackRock Health Sciences | N/A | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| Rakesh Jain | Tekla Healthcare Investors | 69 | |
| Joseph Beranek | Columbia Seligman Premium | 55 | |
| John Maney | Pimco Corporate Income | 62 | |
| Dr MS | Tekla Healthcare Investors | 72 | |
| Karen Gilomen | Reaves Utility If | 49 | |
| Stacie Anctil | Pimco Corporate Income | 51 | |
| Jay Fife | BlackRock Health Sciences | 51 | |
| Michael Holland | Reaves Utility If | 75 | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
| Cynthia Frost | Eaton Vance Enhanced | 60 | |
| Helen Peters | Eaton Vance Enhanced | 73 | |
| Lisa Phelan | Cohen Steers Reit | 51 | |
| Robert Hubbard | BlackRock Health Sciences | 63 | |
| Frank Gentile | Tekla Healthcare Investors | 63 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.